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Silvia Bielsa, MD,* Jose´ Martín-Juan, MD,† Jose´ M. Porcel, MD,*
and Francisco Rodríguez-Panadero, MD†
Background and objective:We aimed to examine the frequency of
pleural adhesions and to determine their relationship with pleural
tumor burden, pleural fluid (PF) biochemistries, PF cytologic yield,
and survival in patients with malignant pleural effusion (MPE).
Methods: We performed retrospective analysis of 540 consecutive
patients with MPE who underwent medical thoracoscopy. Pleural
lesion rating and grade of pleural adhesions based on a thoraco-
scopic score model were recorded.
Results: Sixty percent of patients with MPE were found to have
adhesions in the pleural space. The sensitivity of PF cytology was
71% if there were no pleural adhesions, and 20% if the maximum
adhesion score was reached (p  0.01). The extent of pleural
adhesions correlated positively with the pleural tumor burden, and
inversely with PF pH. The median survival of patients with minimal
or no adhesions in the pleural space was 9 months as compared with
patients with the highest grade of adhesions, whose median survival
was 5 months (p  0.01).
Conclusion: MPE are often loculated. The higher the grade of
pleural adhesions, the greater the tumor burden exists, and paradox-
ically the lower the PF cytologic yield. The presence of pleural
adhesions in MPE implies a poor prognosis.
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Thoracoscopy is the recommended procedure for patientswith an undiagnosed exudative effusion and negative
pleural fluid (PF) cytology who are suspected of having a
malignancy.1 In a prospective study by Loddenkemper and
coworkers, 208 patients with malignant pleural effusion
(MPE) underwent simultaneous closed pleural biopsy (using
a tru-cut needle), PF cytology, and thoracoscopic pleural
biopsy. They found that thoracoscopy had a sensitivity of
95% for diagnosing malignancy as compared with 44% for
closed pleural biopsy and 62% for PF cytology.2 Similar
results have been reported by other investigators.3
The presence of pleural adhesions may prevent full
examination of the pleural cavity and thus reduce the success
of a thoracoscopic procedure.4 In addition, it could increase
the risk of lung injury during trocar placement if ultrasound
is not used.5 PF may become encapsulated by adhesions
between the parietal and the visceral pleura in conditions that
cause pleural inflammation, such as empyema, tuberculosis,
or hemothorax.6 However, reports documenting the fre-
quency of adhesions in different types of pleural tumors and
their influence on PF cytologic yield or prognosis of the MPE
are lacking. Additionally, no study has evaluated the relation-
ship that pleural adhesions might have with the tumor burden
found in the pleural cavity.
The present study analyzes a large thoracoscopic series
of patients with MPE to determine the frequency of pleural
adhesions and their relationship with the type of tumor, the
tumor burden, the PF biochemistry, the diagnostic yield of PF
cytology, and the patient’s survival.
METHODS
Patients
Information gathered on all patients who undergo di-
agnostic or therapeutic thoracoscopic examination at the
University Hospital Virgen del Rocío (Sevilla, Spain) is
stored in a prospectively maintained database. A retrospec-
tive analysis was performed only on those patients with a
confirmed pleural malignancy from January 1982 to April
2007. An MPE was defined by the presence of malignant
cells either in the PF examination or in the pleural tissue
obtained at thoracoscopy, thoracotomy, or autopsy. The local
ethics committee approved this study.
Data Collection
The evaluation of patients included age, gender, symp-
tom chronology, size of the pleural effusion in a postero-
anterior chest radiograph, appearance of PF (bloody versus
nonbloody), PF biochemistry (cell count, total protein, glu-
cose, lactate dehydrogenase [LDH], and pH), PF cultures on
bacterial and mycobacterial media, PF cytology, thoraco-
scopic findings (i.e., pleural lesion rating, presence and extent
of adhesions, pleural histology), final diagnosis, and primary
tumor.
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The PF total protein, LDH and glucose concentrations
were determined by standard methodologies. The PF sample
for pH measurement was taken under anaerobic conditions
with a syringe rinsed with heparin and measured in a blood
gas analyzer. A cytologic examination was done using the
Papanicolau smear.
Massive pleural effusions were defined as those effu-
sions occupying the entire hemithorax in a postero-anterior
chest radiography.
Tumor Burden and Pleural Adhesion Rating
Medical thoracoscopy was performed under local an-
esthesia using a 10-mm thoracoscope with a single entry.
Pleural tumor burden was rated at the time of thoracoscopy,
using a locally developed scoring system that was published
a decade after the study began.7 That system ranges from a
minimum of 0 to a maximum of 9 and consists of an
incremental scale from 0 to 3 that reflects the morphologic
extent of diaphragmatic, costoparietal, and visceral pleural
involvement. For each pleural surface, a score of 0 represents
no visible disease; a score of 1 represents focal disease
(thickening or tumor nodules) covering a small, distinct part
of the pleural surface; a score of 2 represents extensive
disease covering most of the pleural surface; and a score of 3
represents diffuse disease covering the entire pleural surface.
The sum of individual scores for each of these surfaces
provides a maximum score of 9.
The presence of adhesions in the pleural cavity was also
rated during the thoracoscopic procedure, using a locally
developed scoring system, but later published score,8 ranging
from a minimal of 0 to a maximum of 4. One point was
assigned to isolated adhesions that permitted thoracoscopy
without problems, 2 points to adhesions that obstructed about
one third of the vision, 3 points to adhesions that obstructed
about two thirds of the vision and 4 points to adhesions of
sufficient density to preclude entry into the pleural space. In
this case, biopsies were taken from the thickened pleura at the
site of planned entry. All thoracoscopic examinations were
fully video-recorded and, therefore, both pleural tumor bur-
den and adhesion rating could be rechecked at any time, if
necessary.
Statistical Analysis
Continuous variables were expressed as the mean (SD)
or median (interquartile range) as appropriate. Analysis of
variance evaluated differences in PF biochemistries accord-
ing to the grade of pleural adhesions, and also in the grade of
adhesions at thoracoscopy in relation to the type of tumor and
lesion rating. Cytologic sensitivity values and their 95%
confidence intervals (CI) were calculated from a standard 2
2 table. Logistic regression analyses were used to assess the
relationship between sensitivity of PF cytology and grade of
pleural adhesions. Spearman correlation analysis measured
relationships between: (1) grade of adhesions and PF bio-
chemistries; (2) grade of adhesions and the duration of the
patient’s symptoms; (3) tumor burden and PF biochemistries;
and (4) tumor burden and the duration of the patient’s
symptoms (measured in months). An ordinal logistic regres-
sion analysis was performed for independent predictors of the
pleural grade of adhesions. We used the Kaplan-Meier
method to test the relationship between survival and grade of
pleural adhesions, calculating the 95% CI and using the
log-rank test for comparison. Of note, patients with the 4th
grade of adhesions were excluded from some of these anal-
yses (e.g., correlation with tumor burden) because of the
impossibility of calculating a correct lesion rating when the
pleural space is full of adhesions that prevent complete
inspection. Survival from the time of MPE diagnosis was
analyzed as a function of the grade of adhesions, in addition
to other factors known to be associated with a poor prognosis
(i.e., tumor burden, PF pH, and tumor type),9 using Cox
regression. Results were considered statistically significant at
p  0.05. Statistical software (SPSS version 14.0, Chicago,
IL) was used for the analysis.
RESULTS
Tumor Types
A total of 647 consecutive thoracoscopic examinations
were performed during the study period. Five hundred forty
patients had MPE (mean age 60  13 years, 50.2% males) as
demonstrated by thoracoscopic pleural biopsy. The primary
tumors are shown in Table 1. Analysis of histologic types
indicated that the great majority of these malignancies were
adenocarcinomas, (326) followed by mesotheliomas, (79)
lymphomas,(47) epidermoid carcinomas,(33) small-cell car-
cinomas, (14) undifferentiated carcinomas (13), and sarco-
mas, (28) among others.
Frequency of Pleural Adhesions and
Relationship with PF Biochemical Parameters
At thoracoscopy, 208 of 540 (39%) patients were found
to have no adhesions in the pleural space, 109 (20%) had
TABLE 1. Tumor Type in Patients with Malignant Pleural
Effusion
Tumor type n (%)
Lung 132 (24)
Adenocarcinoma 82 (15)
Squamous 23 (4)
Small-cell 14 (3)
Undifferentiated 9 (2)
Breast 100 (19)
Mesothelioma 79 (15)
Unknown primary 62 (12)
Lymphoma 46 (9)
Ovary 27 (5)
Kidney 24 (4)
Colorectal 18 (3)
Stomach 12 (2)
Sarcoma 12 (2)
Othersa 28 (5)
Total 540
a Eight gynecological, 4 head and neck, 3 thymoma, 3 cholangiocarcinoma, 2
thyroid, 2 urinary bladder, and 1 each melanoma, pancreas, ependymoma, esophagus,
myeloma, and myelodysplastic syndrome.
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isolated adhesions (grade 1), 139 (26%) had grade 2 adhe-
sions, 72 (13%) had grade 3 adhesions, and 12 (2%) had
grade 4 adhesions.
Both the grade of adhesions (Table 2) and the pleural
tumor burden (data not shown) correlated positively with the
mean LDH PF values and inversely with the mean PF levels
of glucose and pH (all p  0.01).
Pleural Adhesions and Sensitivity of Pleural
Fluid Cytology
We found an inverse correlation between the extent of
pleural adhesions and the sensitivity of PF cytology. Cyto-
logic sensitivity in patients without pleural adhesions (grade
0) was 71% (95% CI, 65–77%), whereas sensitivity in those
with the maximum adhesion-score (grade 4) was 20% (95%
CI, 0–50%, p  0.002) (Table 2).
Pleural Adhesions, Tumor Types and Tumor
Burden
Mean pleural adhesion grade differed among tumor
types (p  0.01). A lower grade of pleural adhesions was
observed in lymphoma, breast cancer, and mesothelioma as
compared with sarcoma, colorectal, stomach or kidney tu-
mors (Figure 1). After excluding patients with grade 4 adhe-
sions for the reasons mentioned above, the adhesion score
also increased with the extent of tumor on the pleural surfaces
-tumor burden- (p  0.01) (Figure 2).
There was no significant correlation between the duration of
symptoms (measured in months) and tumor burden (p  0.87) or
the extent of pleural adhesions (p  0.54). Patients had pleural-
related symptoms for a median (interquartile range) of 2 (1–4)
months before the performance of the thoracoscopic procedure.
FIGURE 1. Relationship between
mean grade of adhesions found at
thoracoscopy and tumor type. Pleu-
ral adhesions grade is presented as
a continuous variable. Mean differ-
ences are significant by the analysis
of variance method (p  0.01).
TABLE 2. Pleural Fluid Biochemistries and Cytological Yield at Different Grades of Pleural
Adhesion
Grade
of Adhesions n (%)
PF Glucose,
mg/dla PF pHa
PF LDH,
IU/litera
Sensitivity of Cytology
(95% CI)b
Grade 0 208 (38.5) 92  52 7.35  0.08 638  539 71 (65–77)
Grade 1 109 (20.2) 85  47 7.34  0.08 892  1145 62 (52–71)
Grade 2 139 (25.7) 79  46 7.31  0.11 1141  1558 61 (53–70)
Grade 3 72 (13.3) 59  45 7.24  0.14 1568  2065 56 (45–68)
Grade 4 12 (2.2) 87  12 7.37  0.01 677  763 20 (0–50)
Total 540 82  49 7.32  0.11 951  1301 63 (59–68)
Values are given as mean  SD.
a Differences are significant by the analysis of variance method (p  0.01).
b Differences are significant by logistic regression analyses (p  0.01).
PF, pleural fluid; LDH, lactate dehydrogenase; CI, confidence intervals.
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Predictors of Higher Grade of Pleural
Adhesions in the Multivariate Analysis
An ordinal logistic regression analysis showed the
following variables as predictors of a higher grade of
pleural adhesions (considering up to a grade 3 adhesion
score): PF pH  7.21, negative cytology and high lesion
rating (Table 3).
Pleural Adhesions and Survival
The median survival of patients without pleural adhe-
sions or with isolated adhesions was 9 months, whereas that
of patients with adhesions of grades 2 and 3 was around 5
months (p 0.01) (Table 4). The grade 4 adhesion group was
not deemed suitable for calculations due to the scarce number
of patients (n  12) with a known date of death among this
FIGURE 2. Relationship between
mean grade of adhesions and lesion
rating found at thoracoscopy. Pleu-
ral adhesions grade is presented as
a continuous variable. Circles show
mean value and “I” bars represent
standard deviation value. Mean dif-
ferences are significant (p  0.001)
by the analysis of variance method.
TABLE 3. Variables that Predict the Grade of Pleural Adhesions at Thoracoscopy
Variable Value n (%)
Grade of Adhesions,
Mean (95% CI) pa pb
PF appearance Bloody 186 (37) 1.49 (1.32–1.67) 0.01 0.45
Nonbloody 311 (63) 1.04 (0.92–1.15)
Effusion’s size Massive 86 (16) 1.44 (1.20–1.68) 0.04 0.32
Nonmassive 441 (84) 1.18 (1.07–1.29)
PF pH 7.21 64 (19) 1.92 (1.64–2.20) 0.01 0.02
7.21 278 (81) 1.12 (0.99–1.24)
PF glucose, mg/dl 60 111 (28) 1.61 (1.40–1.82) 0.01 0.74
60 287 (72) 1.04 (0.92–1.17)
PF LDH, UI/liter 1000 289 (76) 1.07 (0.94–1.20) 0.01 0.95
1000 92 (24) 1.57 (1.34–1.81)
PF cytology Negative 189 (36) 1.41 (1.23–1.58) 0.01 0.01
Positive 341 (64) 1.09 (0.97–1.20)
Pleural tumor burden See Figure 2 0.01 0.01
Primary tumor See Figure 1 0.01 0.1
Pleural adhesions grade is presented as a continuous variable to perform the statistic analysis.
a Analysis of variance or Spearman correlation analysis when appropriate.
b Ordinal logistic regression analysis.
PF, pleural fluid; CI, confidence intervals; LDH, lactate dehydrogenase.
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group, which resulted in wide CI. The influence of adhesion
grade on survival did not change over three consecutive time
periods studied (data not shown).
When PF pH, pleural lesion rating and type of tumor, in
addition to the grade of pleural adhesions, were included in a
multivariate analysis of survival, only the first 2 variables
remained as independent predictors of survival (respective
p values 0.04 and 0.01).
DISCUSSION
Fluid loculations are common in inflammatory pleural
exudates, including parapneumonic effusions, tuberculosis,
and hemothoraces.10 Also, the frequency of significant adhe-
sions in MPE seems to be high (40% in this study). Ernst et
al.11 found adhesions in 12 (33%) and loculations in 8 (22%)
of 36 pleuroscopic procedures, 22 of them in patients with
MPE. In one series of 26 patients with symptomatic MPE
who underwent thoracentesis with drainage of 500 ml of PF
per day for 3 consecutive days, pleural fibrin strands were
detected by ultrasonography in 11 patients (42%) on day 6,
suggesting an association between the number of thoracente-
sis and pleural adhesion formation.12 However, Wolff et al.13
were unable to find such a relationship in 74 patients with
MPE submitted to medical thoracoscopy. Half of these pa-
tients had some degree of pleural adhesions, duration of the
effusion more than 5 months being the only significant
predictor of the presence and extent of pleural adhesions.
Contrary to these findings, we failed to find an association
between duration of the effusion and pleural adhesion
formation or grade. Although the exact number of previous
thoracenteses was not recorded in the present study, the
majority of our patients had been subjected to more than
one diagnostic and/or therapeutic thoracentesis before
medical thoracoscopy.
There is not an accepted grading system for the extent
of pleural adhesions.14 Chest sonography and computed to-
mography have only moderate utility in predicting adhesions
seen during thoracoscopy.5,14,15 For example, Sasaki et al.5
found a sensitivity of 81.5% and a specificity of 81% in
detecting pleural adhesions with ultrasonography in a series
of 42 patients who underwent thoracotomy or video-assisted
thoracic surgery. Mason et al.14 correctly identified pleural
adhesions by computed tomography in 28 of 39 cases
(sensitivity 71%) and ruled out adhesions in 18 of 25 cases
(specificity 72%); the surgeon confirmed or excluded each
suspected adhesion during video-assisted thoracoscopic
surgery.
For uncertain reasons, we found an inverse correlation
between the extent of adhesions and cytologic sensitivity,
despite the correlation between a higher grade of pleural
adhesions and a greater tumor burden. Whether this is the
result of patients with pleural adhesions having a compart-
mentalized cell distribution affecting areas not sampled dur-
ing thoracentesis or because they do not exfoliate a sufficient
number of cells into the pleural cavity because of a fibrin
layer is a matter of speculation.
Pleural inflammation results in fibrin deposition, which
may additionally initiate a sequence of events that lead to
tissue remodeling and ultimate fibrosis.16,17 The grade of
adhesions in a pleural effusion may vary according to the
underlying cause of pleural inflammation and the balance
between coagulation and fibrinolysis.18,19 Compared with
free-flowing pleural effusions, pleural inflammation is in-
creased in loculated pleural effusions.10 A study that com-
pared the differences between loculated and free-flowing
effusions of different etiologies (29 malignancies, of which
11 were loculated, 19 tuberculosis and 30 pneumonias)
showed a higher intensity of pleural inflammation in the
former via release of various mediators and proteins.10 We
found that the pleural adhesion grade paralleled tumor bur-
den; therefore there may be a link between pleural inflam-
mation and tumor burden. Likewise, PF acidosis, low PF
glucose, and high LDH concentrations, well known markers
of intense pleural inflammation,20 were associated with a high
tumor burden and grade of adhesions. We also observed that
the prolonged duration of the patient’s symptoms was not
necessarily indicative of the higher extent of pleural cancer or
the higher grade of pleural adhesions during thoracoscopic
visualization. This seems to be an apparent paradox, but an
intrinsically different aggressive tumor could produce vari-
able amounts of procoagulant-fibrinolytic mediators into the
pleural space,7 therefore leading to a different grade of
adhesion.
The prognosis of patients with MPE is poor. In a
meta-analysis, the median survival of 417 patients with MPE
was only 4 months.21 It is generally thought that the most
important factor influencing life expectancy in patients with
MPE is the primary tumor.9 However, no study has specifi-
cally evaluated the tumor burden as a factor of poor progno-
sis. Instead, a low PF pH or glucose or a high PF LDH
concentration are well recognized predictors of poor survival,
yet they reflect, as the grade of pleural adhesions, a greater
tumor burden in the pleural space.9 This may explain why in
our multivariate survival analysis the grade of pleural adhe-
sions lost significance.
This study has limitations. The scores used for tumor
burden and pleural adhesions need to be validated in further
studies. In addition, we only studied patients who were
suitable for undergoing thoracoscopy. Therefore, our findings
probably could not be generalized to all patients with MPE.
In conclusion, this study demonstrates that significant
pleural adhesions (grades 2–4) occur in more than one third
of patients with MPE, and that pleural adhesions, which
parallel tumor burden, correlate with a lower PF cytologic
sensitivity and survival expectancy.
TABLE 4. Survival Depending on the Grade of Pleural
Adhesions
Grade of Adhesions n Median Survival, mo (95% CI)a
0 208 9 (5–13)
1 109 9 (6–12)
2 139 5.4 (3.8–7.1)
3 72 4.8 (2.7–6.8)
a Differences are significant by the Kaplan-Meier method with the log rank test
(p  0.01).
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